Anti-tumor activity of naive and activated class I-restricted tumor-specific TCR-transgenic T cells.

被引：0
|
作者：
Dalyot-Herman, N [1 ]
Malek, TR [1 ]
机构：
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
来源：
FASEB JOURNAL | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A613 / A613
页数：1
相关论文
共 50 条
  • [41] Identification and Characterization of HLA Class I-Restricted MYD88 L265P-Derived Peptides As Tumor-Specific Targets for Immunotherapy
    Nelde, Annika
    Stickel, Juliane S.
    Kowalewski, Daniel Johannes
    Wolz, Oliver Olaf
    Kanz, Lothar
    Langerak, Anton W.
    Muggen, Alice F.
    Bonzheim, Irina
    Fend, Falko
    Rammensee, Hans-Georg
    Stevanovic, Stefan
    Weber, Alexander N. R.
    BLOOD, 2015, 126 (23)
  • [42] ANTI-TUMOR EFFECT OF ALLOGENEIC LYMPHOCYTES SENSITIZED WITH TUMOR-SPECIFIC IMMUNE RNA ON HUMAN CANCER-CELLS
    FUKUSHIMA, M
    MACHIDA, S
    NISHIKAWA, T
    ISHIKAWA, Y
    CELLULAR AND MOLECULAR BIOLOGY, 1979, 25 (01) : 39 - 45
  • [43] In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8+ cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer
    Santin, AD
    Hermonat, PL
    Ravaggi, A
    Bellone, S
    Pecorelli, S
    Cannon, MJ
    Parham, GP
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (03) : 601 - 609
  • [44] Probiotic lactic acid bacteria promote anti-tumor immunity through enhanced major histocompatibility complex class I-restricted antigen presentation machinery in dendritic cells
    Saito, Suguru
    Okuno, Alato
    Peng, Zhenzi
    Cao, Duo-Yao
    Tsuji, Noriko M.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [45] Electroporation of TCR encoding RNA into T cells as a new approach for anti-tumor immunotherapy
    Schaft, N.
    Doerrie, J.
    Birkholz, K.
    Hoyer, S.
    Wellner, V.
    Mueller, I.
    Kaempgen, E.
    Schuler, G.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 220 - 220
  • [46] Enhancing the anti-tumor activity of T cells by improving the expression of the TCR chains using different leader sequences
    Djanashvili, V. Raz
    Fried, M.
    Cohen, C. J.
    HUMAN GENE THERAPY, 2013, 24 (03) : A12 - A12
  • [47] The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
    Jiangping Li
    Zhiwen Xiao
    Donghui Wang
    Lei Jia
    Shihong Nie
    Xingda Zeng
    Wei Hu
    Molecular Cancer, 22
  • [48] Deficient CD4(+) T cell proliferation in the class I MHC-restricted 2C TCR-transgenic mouse
    Chen, FL
    Kung, JT
    JOURNAL OF IMMUNOLOGY, 1996, 156 (06): : 2036 - 2044
  • [49] The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
    Li, Jiangping
    Xiao, Zhiwen
    Wang, Donghui
    Jia, Lei
    Nie, Shihong
    Zeng, Xingda
    Hu, Wei
    MOLECULAR CANCER, 2023, 22 (01)
  • [50] Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity
    Marzo, AL
    Kinnear, BF
    Lake, RA
    Frelinger, JJ
    Collins, EJ
    Robinson, BWS
    Scott, B
    JOURNAL OF IMMUNOLOGY, 2000, 165 (11): : 6047 - 6055
12345